PARK INNOVAARE
INNOVAARE AG
SWITZERLAND INNOVATION
CERN BIC
About the BIC
Up-and-coming and established technology leaders
Already at PARK INNOVAARE
At PARK INNOVAARE, we offer high-tech companies of all sizes the best possible conditions for cross-industry collaboration and the realization of their R&D projects. With our modern infrastructure, close interaction with the Paul Scherrer Institute PSI, and our network of research and industrial partners, we support our member companies in achieving their next breakthrough.
Advanced Accelerator Technologies AG
Advanced Accelerator Technologies AG (AAT) was founded in 2015 as a joint initiative between the Paul Scherrer Institute PSI and a range of industry partners. The main aim of AAT is to commercialize the PSI's leading know-how concerning accelerators, experimentation, and large facilities, as well as the institute's outstanding application expertise regarding particle beams and photons in the areas of science, research, and industrial processes.
Crystallise! AG
Crystallise! AG is a young company that provides crystallographic services for identifying small molecule compounds and targets the chemical, pharmaceutical, and agro-industries.
Cosylab Switzerland GmbH
Cosylab Switzerland GmbH provides systems integration and customized products and solutions, covering the full range of control systems and instrumentation. Cosylab Switzerland was involved in the development of large-scale distributed control systems for PSI's SwissFEL and SLS facilities.
Datalystica Ltd.
Datalystica is a spin-off of the laboratory of atmospheric chemistry (LAC) at the Paul Scherrer Institute PSI. The company offers fast software solutions for factor analytic problems on multivariate data, any kind of data. The main product is an extremely user-friendly and powerful software package called the Source Finder (SoFi).
ELDICO SCIENTIFIC AG
ELDICO SCIENTIFIC AG (The Electron Diffraction Company) is a Swiss deep tech company founded in 2019. ELDICO develops, produces and sells electron diffractometers (ED) for the analysis of compounds enabling industrial and scientific researchers to characterize hitherto unmeasurable nanocrystalline systems where conventional methods (X-ray) fail.
Given diffraction methods are only applicable to solid particles of sub-millimeter (micrometer) sizes. ED overcomes the limitations and allows investigations on nanocrystalline systems of at least 1 million times smaller in volume. Hundreds of thousands of known but not fully characterized solid substances could be rapidly screened for their commercial potential. ELDICO technology will help to triple the number of drug candidates and help the pharmaceutical industry to accelerate the drug discovery process. It is a disruptive innovation, that will open fascinating new commercial perspectives not only to the pharmaceutical industry but also agrochemical, chemical, and advanced materials industries.
Expose GmbH
Photo credits: Expose GmbH
Expose GmbH is a spin-off company of the Paul Scherrer Institute PSI founded in 2008. The company offers services in protein crystallography to pharmaceutical and biotechnological companies providing fast and affordable access to synchrotron beamtime at the Swiss Light Source (SLS) and its expertise in data processing and protein structure solution.
Excelsus Structural Solutions (Swiss) AG
Excelsus is a spin-off company of the Paul Scherrer Institute PSI. It offers fast, easy, and affordable access to state-of-the-art characterization tools for the structural and microstructural analysis of materials (pharmaceuticals, food and aroma compounds, pigments, polymers, and various other chemicals) for selecting, developing and manufacturing high-quality products.
GratXray AG
GratXray, a high-tech spin-off of the PSI and ETH Zurich, is developing, producing, and commercializing a grating interferometry-based breast computed tomography (GIBCT) system. Their technology allows for more precise breast cancer imaging. It will significantly reduce the number of false positives and improve patients' comfort during the procedure.
InterAx Biotech AG
InterAx is uniquely positioned to assist GPCR drug candidate design and selection by integrating bioanalytical and computational pharmacology on collaborative projects with biotech and pharma companies. InterAx applies mathematical models and simulations to in-house-derived bioanalytical data to address the complexity of drug-induced cellular signaling mechanisms. The company's goal is to close the gap between laboratory experiments and in vivo studies by streamlining the critical processes of drug candidate design and selection, thereby significantly reducing the risks, costs and duration of drug discovery and the development of new drugs.
leadXpro AG
Specializing in the development and optimization of pharmaceutically active substances, leadXpro AG applies research from the Paul Scherrer Institute PSI in the field of membrane proteins, as well as world-leading technologies to investigate protein structures. The new large research facility at the PSI, the SwissFEL (launched in 2016), also offers excellent potential for this close collaboration.
Molecular Modeling Laboratory (MML)
Molecular Modeling Laboratory (MML) applies high-throughput quantum chemical modeling, Artificial Intelligence (AI) heuristics, and state-of-the-art electron microscopy to the study and development of life science immunointerventions and drug design. Quantum Immunology, MML's flagship initiative, addresses how quantum mechanics translate into receptor-antigen triggering and how this knowledge may be applied to the therapy of infectious diseases, immune disorders, neurological conditions and aging. MML also combines theoretical modeling and Electron Energy Loss Spectroscopy (EELS) to optimize drug design by detecting new polymorphic crystal structures and analyzing pharmaceutical Amorphous Solid Dispersion (ASD) dynamics.
Securaxis AG
Using AI, sound localization, and Internet of Things (IoT) technology, Securaxis has developed a real-time high-energy event detection sensor to identify and characterize sounds. It is designed to be integrated into the environment where video camera installations are not suitable for technical or privacy reasons. Their device will help authorities (police, traffic authorities, fire departments) overcome daily challenges by providing early awareness signals when there are explosions or extreme energy events, such as fires or collisions, thus keeping them informed of ongoing situations in real time and reducing the number of false alarms.
Swiss Hydrogen SA
Swiss Hydrogen SA was founded in 2008 as a subsidiary of Belenos Clean Power Holding to develop and market electrolysis products and services. The company works on clean energy solutions based on hydrogen for a variety of applications, enabling zero-emission electricity production. In 2018, French automotive supplier Plastic Omnium acquired Swiss Hydrogen.
Swiss Terahertz GmbH
Swiss Terahertz ist ein Start-up, dessen einzigartige Terahertz-Technologien zu den fortschrittlichsten der am SwissFEL entwickelten Verfahren im Bereich der Terahertz-Strahlung zählen. Das Unternehmen legt den Schwerpunkt auf Erforschung, Entwicklung und Produktion von Terahertz-Systemen und hocheffizienten nichtlinearen organischen Kristallen. Die Produkte von Swiss Terahertz können sowohl in spezialisierte Forschungsinfrastrukturen als auch in kommerzielle Spektrometer für sicherheitstechnische Prüfung, Pharmatests und zerstörungsfreie Qualitätskontrolle integriert werden.
Do you want to stay up to date on the latest technological developments? Do you want to know more about new up-and-coming start-ups and spin-offs? Do you want to be part of the innovation ecosystem at PARK INNOVAARE? Simply subscribe to our newsletter or follow us on social media!
PARK INNOVAARE: deliveryLAB
5234 Villigen
info@parkinnovaare.ch
innovaare@switzerland-innovation.com
Home Contact Career Media Corner Event Archive Innovation library Legal notice
FOUNDATION PARK BASEL AREA PARK ZURICH PARK NETWORK WEST EPFL PARK BIEL/BIENNE
© 2019 innovAARE AG